IRITERO is indicated for the treatment of patients with advanced colorectal cancer: In combination with 5-fluorouracil and Folinic acid in patients without prior chemotherapy for advanced disease; As a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen.
Irinotecan combination with Cisplatin is indicated for treatment of patients with small cell lung cancer.
Strictly follow the recommended dosage unless directed otherwise by the physician.